152 related articles for article (PubMed ID: 35216862)
1. Incorporation of sentinel lymph node biopsy in cervical cancer surgery: Recent U.S. trends.
Matsuo K; Klar M; Ciccone MA; Nusbaum DJ; Shimada M; Roman LD; Wright JD
Eur J Surg Oncol; 2022 Jun; 48(6):1407-1413. PubMed ID: 35216862
[TBL] [Abstract][Full Text] [Related]
2. Uptake in sentinel lymph node biopsy for endometrial cancer with T3 classification.
Matsuo K; Klar M; Khetan VU; Vallejo A; Violette CJ; Tavakoli A; Nusbaum DJ; Roman LD; Wright JD
Gynecol Oncol; 2022 May; 165(2):361-368. PubMed ID: 35272876
[TBL] [Abstract][Full Text] [Related]
3. Population-level trends and outcomes of sentinel lymph node biopsy in vulvar cancer surgery in the United States.
Brunette LL; Khetan VU; Deshpande RR; Nusbaum DJ; Klar M; Roman LD; Wright JD; Matsuo K
Gynecol Oncol; 2022 Mar; 164(3):651-657. PubMed ID: 35031190
[TBL] [Abstract][Full Text] [Related]
4. Utilization of sentinel lymph node biopsy in the early ovarian cancer surgery.
Matsuo K; Klar M; Barakzai SK; Jooya ND; Nusbaum DJ; Shimada M; Roman LD; Wright JD
Arch Gynecol Obstet; 2023 Feb; 307(2):525-532. PubMed ID: 35595998
[TBL] [Abstract][Full Text] [Related]
5. Association between sentinel lymph node biopsy and micrometastasis in endometrial cancer.
Matsuo K; Klar M; Khetan VU; Violette CJ; Youssefzadeh AC; Yessaian AA; Roman LD
Eur J Obstet Gynecol Reprod Biol; 2022 Aug; 275():91-96. PubMed ID: 35763967
[TBL] [Abstract][Full Text] [Related]
6. Implementing a Cervical Sentinel Lymph Node Biopsy Program: Quality Improvement in Gynaecologic Oncology.
Cusimano MC; Walker R; Bernardini MQ; Bouchard-Fortier G; Laframboise S; May T; Murphy J; Rosen B; Covens A; Clarke B; Shaw P; Rouzbahman M; Mohan R; Ferguson SE
J Obstet Gynaecol Can; 2017 Aug; 39(8):659-667. PubMed ID: 28729099
[TBL] [Abstract][Full Text] [Related]
7. Increasing trends of cervical conization with lymph node evaluation for fertility-sparing surgery in early cervical cancer.
Furey KB; Anderson ZS; Kuznicki ML; Klar M; Roman LD; Wright JD; Matsuo K
Gynecol Oncol; 2023 Jun; 173():122-129. PubMed ID: 37137189
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node mapping with indocyanine green in cervical cancer patients undergoing open radical hysterectomy: a single-institution series.
Bizzarri N; Luigi PA; Ferrandina G; Zannoni GF; Carbone MV; Fedele C; Teodorico E; Gallotta V; Gueli Alletti S; Chiantera V; Fagotti A; Scambia G; Fanfani F
J Cancer Res Clin Oncol; 2021 Mar; 147(3):649-659. PubMed ID: 33000339
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node biopsy for stage II endometrial cancer: Recent utilization and outcome in the United States.
Matsuo K; Klar M; Khetan VU; Violette CJ; Nusbaum DJ; Muderspach LI; Roman LD; Wright JD
Gynecol Oncol; 2022 Jan; 164(1):46-52. PubMed ID: 34728108
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer.
Salvo G; Ramirez PT; Levenback CF; Munsell MF; Euscher ED; Soliman PT; Frumovitz M
Gynecol Oncol; 2017 Apr; 145(1):96-101. PubMed ID: 28188015
[TBL] [Abstract][Full Text] [Related]
11. Survival of Patients with Serous Uterine Carcinoma Undergoing Sentinel Lymph Node Mapping.
Schiavone MB; Scelzo C; Straight C; Zhou Q; Alektiar KM; Makker V; Soslow RA; Iasonos A; Leitao MM; Abu-Rustum NR
Ann Surg Oncol; 2017 Jul; 24(7):1965-1971. PubMed ID: 28258415
[TBL] [Abstract][Full Text] [Related]
12. Outcomes for patients with high-risk endometrial cancer undergoing sentinel lymph node assessment versus full lymphadenectomy.
Holtzman S; Stoffels G; Flint M; Carr C; Prasad-Hayes M; Zeligs K; Blank SV
Gynecol Oncol; 2023 Jul; 174():273-277. PubMed ID: 37270906
[TBL] [Abstract][Full Text] [Related]
13. Utilization and Outcomes of Sentinel Lymph Node Biopsy for Early Endometrial Cancer.
Matsuo K; Klar M; Nusbaum DJ; Hasanov MF; Vallejo A; Ciesielski KM; Muderspach LI; Roman LD; Wright JD
Obstet Gynecol; 2022 May; 139(5):809-820. PubMed ID: 35576340
[TBL] [Abstract][Full Text] [Related]
14. Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma.
Schlappe BA; Weaver AL; McGree ME; Ducie J; Zahl Eriksson AG; Dowdy SC; Cliby WA; Glaser GE; Abu-Rustum NR; Mariani A; Leitao MM
Gynecol Oncol; 2020 Jan; 156(1):62-69. PubMed ID: 31776037
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node biopsy versus pelvic lymphadenectomy in early-stage cervical cancer: a multi-center randomized trial (PHENIX/CSEM 010).
Tu H; Huang H; Xian B; Li J; Wang P; Zhao W; Chen X; Xie X; Wang C; Kong B; Xiao J; Zhang P; Liu J;
Int J Gynecol Cancer; 2020 Nov; 30(11):1829-1833. PubMed ID: 32973117
[TBL] [Abstract][Full Text] [Related]
16. Pathological factors associated with non-sentinel lymph node metastasis in early stage cervical cancer.
Diniz TP; Faloppa CC; Mantoan H; Gonçalves BT; Kumagai LY; Menezes ANO; Badiglian-Filho L; Guimaraes APG; da Costa AABA; De Brot L; Baiocchi G
J Surg Oncol; 2021 Mar; 123(4):1115-1120. PubMed ID: 33524165
[TBL] [Abstract][Full Text] [Related]
17. Indocyanine Green versus Radiotracer with or without Blue Dye for Sentinel Lymph Node Mapping in Stage >IB1 Cervical Cancer (>2 cm).
Di Martino G; Crivellaro C; De Ponti E; Bussi B; Papadia A; Zapardiel I; Vizza E; Elisei F; Diestro MD; Locatelli L; Gasparri ML; Di Lorenzo P; Mueller M; Buda A
J Minim Invasive Gynecol; 2017; 24(6):954-959. PubMed ID: 28571944
[TBL] [Abstract][Full Text] [Related]
18. Role of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node low-volume metastasis in early-stage cervical cancer.
Bizzarri N; Pedone Anchora L; Zannoni GF; Santoro A; Valente M; Inzani F; Gallotta V; Conte C; Chiantera V; Fanfani F; Fagotti A; Ferrandina G; Scambia G
Int J Gynecol Cancer; 2020 Mar; 30(3):364-371. PubMed ID: 31980488
[TBL] [Abstract][Full Text] [Related]
19. Survival after sentinel node biopsy alone in early-stage cervical cancer: a systematic review.
Mauro J; Viveros-Carreño D; Vizzielli G; De Ponti E; Fanfani F; Ramirez PT; Buda A
Int J Gynecol Cancer; 2023 Sep; 33(9):1370-1375. PubMed ID: 37586759
[TBL] [Abstract][Full Text] [Related]
20. Survival associated with the use of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node metastasis in cervical cancer.
Bizzarri N; Fedele C; Teodorico E; Certelli C; Pedone Anchora L; Carbone V; Giannarelli D; Fagotti A; Zannoni GF; Valente M; Querleu D; Ferrandina G; Scambia G; Fanfani F
Eur J Surg Oncol; 2024 Apr; 50(4):108250. PubMed ID: 38461568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
